gw420867x has been researched along with mannitol in 2 studies
| Studies (gw420867x) | Trials (gw420867x) | Recent Studies (post-2010) (gw420867x) | Studies (mannitol) | Trials (mannitol) | Recent Studies (post-2010) (mannitol) |
|---|---|---|---|---|---|
| 17 | 5 | 2 | 13,114 | 685 | 2,583 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, L; Humphreys, JE; Morgan, JB; Polli, JW; Serabjit-Singh, CS; Webster, LO; Wring, SA | 1 |
| Cass, L; Prince, W; Segal, M; Thomas, S | 1 |
2 other study(ies) available for gw420867x and mannitol
| Article | Year |
|---|---|
Rational use of in vitro P-glycoprotein assays in drug discovery.
Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Chromatography, Liquid; Enzyme Inhibitors; Fluoresceins; Fluorescent Dyes; Humans; Mass Spectrometry; Pharmacology; Spodoptera | 2001 |
Brain and CSF entry of the novel non-nucleoside reverse transcriptase inhibitor, GW420867X.
Topics: Animals; Blood-Brain Barrier; Brain; Capillaries; Chemical Phenomena; Chemistry, Physical; Guinea Pigs; Mannitol; Quinoxalines; Reverse Transcriptase Inhibitors; Solubility | 2000 |